Skip to content

Comparison of One-port and Two-port Tissue Expanders for Breast Reconstruction

Randomized Clinical Trial Comparing 1-Port and 2-Port Tissue Expanders for Breast Reconstruction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02725801
Enrollment
20
Registered
2016-04-01
Start date
2016-02-29
Completion date
2020-04-01
Last updated
2020-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

Appropriate patients undergoing going immediate breast reconstruction with tissue expanders following mastectomy will be randomized to receive one-port or two-ports tissue expanders. Their clinical course, complications, and outcome will be analyzed.

Detailed description

The goal of this study is to compare a traditional single port expander with a two-port expander for equivalency when used for breast reconstruction following mastectomy. Complication rates that will be tracked include seroma, mastectomy skin flap necrosis, infection, wound dehiscence, need for explantation of the expander. Management of seromas will be compared between the two groups. The investigators hypothesize that the AlloX2 expander will be as effective in achieving the final outcome of completion of the second stage of reconstruction with equal or improved complication rates. Study Design A prospective 1:1 randomized, single center, open label study will compare the traditional 1- port tissue expander with the AlloX2 2-port expander placed during immediate tissue expander breast reconstruction. Due to the nature of the surgery, the study cannot be blinded. Patients will be followed until completion of expansion and exchange for the permanent implant which typically takes 2 to 3 months. Risks factors that have been previously identified to be associated with increased postoperative complications include smoking, obesity, breast size, diabetes, radiation therapy, and expander fill volume will be identified. The final outcome is completion of expansion and exchange to permanent implant. Standard operative procedure and postoperative care will be done. Both groups will have the same two external drains placed which is standard operative procedure. Complications will be noted at each postoperative clinic visit and entered into a database. Complication rates will be compared between the two groups and associations with risk factors will be analyzed. There will be no cross-over into the other group in case of reconstructive failure. Treatment failures will be treated in the same fashion in the two groups.

Interventions

DEVICEAllergen one-port tissue expander placement

patients will be randomized to receive a one port or two port tissue expander for breast reconstruction

DEVICEAlloX2 two-port tissue expander placement

patients will be randomized to receive a one port or two port tissue expander for breast reconstruction

Sponsors

Lesley Wong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patient agrees to immediate tissue expander breast reconstruction * a suitable patient for tissue expander reconstruction

Exclusion criteria

* not a surgical candidate for immediate breast reconstruction * age less than 18 * patient declines tissue expander reconstruction * patient anticipated to need radiation therapy postoperatively

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Successful Replacement of Tissue Expander With Permanent Implant3 monthsThe number of patients that are able to undergo replacement of the tissue expander between the two arms will be compared

Secondary

MeasureTime frameDescription
Number of Participants Who Required Additional Intervention3 monthsNumber of participants requiring additional intervention following tissue expander placement will be compared between the two arms of the study

Countries

United States

Participant flow

Participants by arm

ArmCount
One-port
intervention is placement of one-port tissue expander at time of reconstruction Allergen one-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction
8
Two-port
intervention is placement of two-port tissue expander at time of reconstruction AlloX2 two-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction
12
Total20

Baseline characteristics

CharacteristicTwo-portTotalOne-port
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants3 Participants0 Participants
Age, Categorical
Between 18 and 65 years
9 Participants17 Participants8 Participants
Age, Continuous51.08 years
STANDARD_DEVIATION 13.83
48.92 years
STANDARD_DEVIATION 3.06
46.75 years
STANDARD_DEVIATION 12.28
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
12 participants20 participants8 participants
Sex: Female, Male
Female
12 Participants20 Participants8 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 80 / 12
serious
Total, serious adverse events
1 / 84 / 12

Outcome results

Primary

Number of Participants With Successful Replacement of Tissue Expander With Permanent Implant

The number of patients that are able to undergo replacement of the tissue expander between the two arms will be compared

Time frame: 3 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
One-portNumber of Participants With Successful Replacement of Tissue Expander With Permanent Implant8 Participants
Two-portNumber of Participants With Successful Replacement of Tissue Expander With Permanent Implant12 Participants
Secondary

Number of Participants Who Required Additional Intervention

Number of participants requiring additional intervention following tissue expander placement will be compared between the two arms of the study

Time frame: 3 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
One-portNumber of Participants Who Required Additional Intervention1 Participants
Two-portNumber of Participants Who Required Additional Intervention4 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026